Office of Health Economics

The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.

Futuros (0)

Lo sentimos: no hay próximos eventos

Pasados (31)

Imagen principal de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Gratis

Imagen principal de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Gratis

Imagen principal de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Gratis

Imagen principal de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Gratis

Imagen principal de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Gratis

Imagen principal de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Gratis

Imagen principal de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Gratis

Imagen principal de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Gratis

Imagen principal de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Gratis

Imagen principal de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Gratis

Imagen principal de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Gratis

Imagen principal de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Gratis

Imagen principal de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Gratis

Imagen principal de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Gratis

Imagen principal de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Gratis

Imagen principal de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Gratis

Imagen principal de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Gratis

Imagen principal de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Gratis

Imagen principal de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Gratis

Imagen principal de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Gratis

Imagen principal de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Gratis

Imagen principal de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Gratis

Imagen principal de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Gratis

Imagen principal de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Gratis

The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.

Eventos

Lo sentimos: no hay próximos eventos
Imagen principal de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Gratis

Imagen principal de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Gratis

Imagen principal de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Gratis

Imagen principal de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Gratis

Imagen principal de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Gratis

Imagen principal de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Gratis

Imagen principal de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Gratis

Imagen principal de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Gratis

Imagen principal de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Gratis

Imagen principal de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Gratis

Imagen principal de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Gratis

Imagen principal de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Gratis

Imagen principal de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Gratis

Imagen principal de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Gratis

Imagen principal de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Gratis

Imagen principal de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Gratis

Imagen principal de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Gratis

Imagen principal de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Gratis

Imagen principal de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Gratis

Imagen principal de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Gratis

Imagen principal de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Gratis

Imagen principal de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Gratis

Imagen principal de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Gratis

Imagen principal de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Gratis